Research-use context: This article is provided for laboratory research and educational purposes only. It is not medical, therapeutic, diagnostic, veterinary, dosing or human-use guidance.
A GHRH analogue
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone. Laboratory and clinical research has examined GHRH-receptor signalling and downstream growth-hormone-axis responses.
Keep pathway research precise
GHRH analogues are not interchangeable with growth-hormone secretagogues that act through other receptors. Accurate naming and receptor context help prevent mechanistically different compounds from being grouped together.
Research evidence spans different settings
Tesamorelin has a substantial clinical literature in defined medical populations, while laboratory research may focus on receptor pharmacology and signalling. Evidence from one setting should not be generalized beyond its studied population or purpose.
References
Wangpaichitr M et al. The development of growth hormone-releasing hormone analogs. Rev Endocr Metab Disord. 2025. PMID 39592529. Recent randomized-trial meta-analysis: PMID 41545261.